Clinical Trial Update: Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) [Phase 2]

View source ↗

Summary

This document announces a Phase 2 clinical trial evaluating Tibulizumab for systemic sclerosis (scleroderma), which is currently recruiting under the TibuSURE s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Tibulizumab (Tibulizumab)

Snippet

Sponsor: Zura Bio Inc | Conditions: Systemic Sclerosis (SSc), Scleroderma | Phase 2 | Status: RECRUITING